Genomics analysis market consolidates towards end-to-end solution
PierianDX has bought Tute Genomics, a move that underscores the trend toward providing an end-to-end solution in clinical genomics analysis to labs.
PierianDX has bought Tute Genomics, a move that underscores the trend toward providing an end-to-end solution in clinical genomics analysis to labs.